CTD-MT 12.5/25/40 Tablet ER

Overview CTD-MT 12.5/25/40 Tablet ER

Combinazione ER tablets (CTD-MT 12.5/25/40mg) effectively manage hypertension by promoting vascular relaxation and optimizing cardiac output. This medication facilitates fluid and electrolyte excretion. While ingestion is independent of meals, consistent timing maximizes therapeutic efficacy. Increased urinary output is typical; therefore, daytime administration, at least four hours pre-sleep, minimizes nighttime voiding. Dosage and frequency are determined by your physician based on individual needs and condition. Continuous use, as directed, is essential. Common side effects include nausea, altered taste perception, diarrhea, and gastrointestinal discomfort. Regular assessment of renal function and electrolyte levels is crucial. Optimal outcomes require lifestyle modifications, including balanced nutrition, regular physical activity, and smoking cessation. Adequate hydration is recommended to counter potential dryness and thirst. Prior to commencing treatment, disclose any pregnancy, circulatory issues, hepatic or renal impairment, and a complete medication history to your doctor, as drug interactions can compromise efficacy or alter the medication's action.

Uses of CTD-MT 12.5/25/40 Tablet ER

Elevated arterial blood pressure

Major Benefits of CTD-MT 12.5/25/40 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the CTD-MT 12.5/25/40 Extended-Release tablet whole; avoid chewing, crushing, or breaking it. While this medication can be taken with or without food, consistent timing is recommended for optimal results.

Common Side effects of CTD-MT 12.5/25/40 Tablet ER:

• Nausea
• Taste change
• Diarrhea
• Upset stomach
• Headache
• Dizziness
• Weakness
• Cold extremities
• Numbness of extremity
• Increased uric acid level in blood
• Increased blood lipid level
• Decreased magnesium level in blood
• Slow heart rate
• Decreased sodium level in blood
• Decreased blood pressure

How to use CTD-MT 12.5/25/40 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; do not chew, crush, or divide it. CTD-MT 12.5/25/40 Extended-Release tablets can be administered with or without food, although consistent timing is recommended.

How CTD-MT 12.5/25/40 Tablet ER works:

Each extended-release CTD-MT tablet (12.5/25/40 mg) merges chlorthalidone, metoprolol succinate, and telmisartan to achieve significant blood pressure reduction.

What if you forget to take CTD-MT 12.5/25/40 Tablet ER :

Should you forget to take a CTD-MT 12.5/25/40 Tablet ER, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.